Megan Chacon, a principal at Fish & Richardson and a member of the firm’s life sciences industry team, answers questions ...

A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

Imagine a gem hunter facing a vast and uncharted landscape to uncover a single beautiful diamond. It is a bit like drug discovery. Scientists create and evaluate hundreds and thousands of molecules in ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

Life sciences companies face challenges transitioning from R&D to clinical trials due to outdated, fragmented technology systems that struggle to support the complexity of later trial phases.

Paul Romness had over two decades of experience as a public and policy affairs expert when his daughter’s best friend’s osteosarcoma diagnosis inspired a new career trajectory.

Pacira BioSciences CEO Frank D. Lee shares three core tenants to improve biopharmaceutical company leadership, especially companies with products capable of disrupting an established therapeutic area.